Medasense Biometrics (מדהסנס ביומטריקס)
Ramat Gan, Israel
Medasense offers a technology that enables clinicians to optimize and personalize pain control and avoid overmedication. Medasense's flagship product, the PMD-200 with its NOL index, is a platform that objectively monitors and quantifies the patient's pain response by means of artificial intelligence and a proprietary noninvasive sensor platform. The PMD-200 is used to optimize pain management in operating rooms and critical care settings, where patients are unable to communicate. The PMD-200 is distributed in Europe exclusively by Medtronic; is cleared for marketing in Canada, Latin America, and Australia; and enables connectivity with Philips patient monitors. Clinical studies have demonstrated its impact on patient safety and outcomes, including opioid sparing.
Only accessible to MedStartr community members.
Join nowCompany Info
- Founded
- 2008
- Website
- medasense.com/
Categories
Only accessible to MedStartr community members.
Join nowWhat do you think of Medasense Biometrics (מדהסנס ביומטריקס)?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.
Only accessible to MedStartr community members.
Join now